Biogen Inc.
BIIB | NASDAQ
$252.06
-$1.56 (-0.62%)
Nov 2, 2026, 10:33 AM ET · Market open
Market Data
Market Cap $37.26B
Enterprise Value $43.99B
Beta 0.17
Average Volume 1.16M
Shares Outstanding (Diluted) 147.8M
Shares Change YoY 0.48%
Institutional Ownership 97.11%
Exchange NASDAQ
ISIN US09062X1037
Price Performance
Price Change 1M 14.6%
Price Change 3M 24.9%
Price Change 6M 34.6%
Price Change YTD 43.2%
Price Change 1Y 66.4%
Price Change 3Y 1.0%
Price Change 5Y -9.8%
1M CAGR (ann.) 17.7%
1Y CAGR (ann.) 71.5%
5Y CAGR (ann.) -0.9%
All-Time CAGR -1.6%
Valuation
PE Ratio 108.38
Forward PE 15.50
PEG Ratio -1.37
Forward PEG -6.45
PS Ratio 3.64
Forward PS 3.50
PB Ratio 1.98
P/FCF Ratio 16.00
P/Adj. FCF Ratio 17.03
P/OCF Ratio 16.69
EV/Sales 4.27
EV/EBIT 77.61
EV/EBITDA 30.37
EV/FCF 18.78
Earnings Yield 0.9%
FCF Yield 6.3%
Adj. FCF Yield 5.9%
Financial Health
Net Debt $6.39B
Total Debt $7.8B
Cash & Short-Term Investments $1.3B
Total Assets $32.05B
Current Ratio 1.95
Quick Ratio 1.37
Debt / Equity Ratio 0.41
Debt / EBITDA 5.39
Debt / FCF 3.33
OCF / Debt 0.29
Interest Coverage 2.58
Altman Z-Score 3.15
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 70.0%
Operating Profit Margin 7.6%
EBITDA Margin 14.1%
Net Profit Margin 3.4%
FCF Margin 22.8%
Adj. FCF Margin 21.4%
SBC / Revenue 1.4%
SBC Impact (per share) -6.0%
Returns
Return on Assets 1.1%
Return on Equity 1.9%
Return on Invested Capital 2.8%
Return on Capital Employed 2.8%
Return on Tangible Assets 3.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 1.0%
Revenue CAGR 5Y -1.5%
Revenue CAGR 10Y -1.0%
EPS CAGR 3Y -38.5%
EPS CAGR 5Y -25.5%
EPS CAGR 10Y -18.3%
FCF CAGR 3Y 31.5%
FCF CAGR 5Y 2.1%
FCF CAGR 10Y -3.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 26
EPS Growth Next 3Y 105.2%
Revenue Growth Next 3Y 3.6%
Earnings Date Feb 5, 2027
EPS Estimate (next Q) $2.85
EPS Growth Est (next Q) 43.2%
Revenue Est (next Q) $2.58B
Revenue Growth Est (next Q) 13.0%
Fair Value Estimates
Graham Number $82.10
Graham Upside -67.6%
Lynch Fair Value $11.70
Lynch Upside -95.4%
Price Target $253.89
Price Target Upside 0.1%
Cash Flow
Operating Cash Flow $2.25B
Free Cash Flow $2.34B
Adj. Free Cash Flow $2.2B
FCF Per Share $15.85
OCF Per Share $15.20
OCF/S Ratio 21.8%
Income Statement
Revenue $10.3B
Gross Profit $7.21B
Operating Income $786.9M
EBITDA $1.45B
Net Income $347.99M
EPS (Diluted) $2.34
Revenue / Employee $1.37M
Profit / Employee $46.4K
Employees 7,500
Add to Watchlist
Select watchlists to add or remove BIIB